首页 | 本学科首页   官方微博 | 高级检索  
     

腹腔热灌注化疗联合高频热疗治疗恶性腹水
引用本文:殷娟,戴鹏,谢正强. 腹腔热灌注化疗联合高频热疗治疗恶性腹水[J]. 武汉大学学报(医学版), 2007, 28(2): 248-250
作者姓名:殷娟  戴鹏  谢正强
作者单位:郧阳医学院附属东风医院肿瘤科,湖北,十堰,442008;郧阳医学院附属东风医院肿瘤科,湖北,十堰,442008;郧阳医学院附属东风医院肿瘤科,湖北,十堰,442008
摘    要:目的:观察腹腔热灌注化疗联合热疗治疗恶性腹水的疗效及其副反应。方法:恶性腹水47例,随机分为治疗组及对照组。腹腔穿刺后连接负压引流器,引流干净腹水后,治疗组给予43-45℃的生理盐水500 ml+顺铂60 mg/m2、生理盐水1 000 ml+5-氟尿嘧啶500 mg/m2,快速灌注入腹腔,使进入腹腔的液体温度维持在42-44℃;灌注结束后,采用HG-2000型高频热疗机行腹腔热疗41-43℃,60 min,每周热疗2次;对照组给予生理盐水60ml+顺铂60 mg/m2、生理盐水100 ml+5-氟尿嘧啶500 mg/m2腹腔内注入。两组均于1 h内完成,每周灌注1次,连续灌注2周,评定疗效。结果:治疗组有效率65.2%,卡氏评分(KPS)升高率47.8%;对照组有效率45.8%,KPS升高率33.3%。治疗组腹水控制率、KPS升高率均较对照组明显为优(P<0.05)。两组副反应无明显差异。结论:腹腔热灌注化疗联合热疗治疗恶性腹水较单纯腹腔化疗疗效好,可以耐受。

关 键 词:恶性腹水  热灌注化疗  高频热疗  顺铂  5-氟尿嘧啶
文章编号:1671-8852(2007)02-0248-03
修稿时间:2006-09-04

Clinical Study of Chemotherapeutic Hyperthermic Intraperitoneal Perfusion Combined with High Freguency Hyperthermia for the Treatment of Malignant Ascites
YIN Juan,DAI Peng,XIE Zhengqiang. Clinical Study of Chemotherapeutic Hyperthermic Intraperitoneal Perfusion Combined with High Freguency Hyperthermia for the Treatment of Malignant Ascites[J]. Medical Journal of Wuhan University, 2007, 28(2): 248-250
Authors:YIN Juan  DAI Peng  XIE Zhengqiang
Affiliation:Dept. of Oncology , Dongf eng Hospital, Yunyang Medical College, Shiyan 442008, China
Abstract:Objective: To evaluate the effects and toxicities of the chemotherapeutic hyperthermic intraperitoneal perfusion(CHIP) combined with hyperthermia for the treatment of malignant ascites.Methods: Forty-seven cases of malignant ascites were randomly divided into treatment group and control group.Normal saline(NS,500 ml) + Cisplatin(60 mg/m2) and 1 000 ml NS + 5-FU 500 mg/m2 for two weeks at 43-45℃ were infused rapidly into abdominal cavity in an hour in treatment group after ascites were drained by peritoneocentesis,then the patients were treated with hyperthermia by external high frequency thermo-therapeutic apparatus HG-2 000(60 min,twice a week).Whereas 0.9% NS 60 ml + Cisplatin 60 mg/m2 and 0.9% NS 100 ml + 5-FU 500 mg/m2 were given in control group without heating.Results: KPS scale increasing rate was 47.8%(11/23) and the response rate of ascites was 65.2% in treatment group versus 33.3%(8/24) and 45.8% in control group respectively(both P<0.05),but the side-effects rate was the same and there were no grade 3 or 4 toxicity in the two groups.Conclusion: The chemotherapeutic hyperthermic intraperitoneal perfusion and hyperthermia was more efficient in the treatment for malignant ascites than the chemotherapy intraperitoneal without heating,while the toxicity and the side-effects were tolerable.
Keywords:Malignant Ascites  Chemotherpeutic Hyperthermic Intraperitoneal Perfusion  High Freguency Hyperthermia  Cisplatin  5-Fluorouracil  Curative Effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号